References
Key articles
Richards BW, Jones FR Jr, Younge BR. Causes and prognosis in 4,278 cases of paralysis of the oculomotor, trochlear, and abducens cranial nerves. Am J Ophthalmol. 1992;113:489-496. Abstract
Erman AB, Kejner AE, Hogikyan ND, et al. Disorders of cranial nerves IX and X. Semin Neurol. 2009;29:85-92. Abstract
Afifi AK, Bergman RA. Functional neuroanatomy: text and atlas. 2nd ed. New York, NY: McGraw-Hill; 2005.
Newman NJ, Dickersin K, Kaufman D, et al. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol. 1996;114:1366-1374. Abstract
Optic Neuritis Study Group. The clinical profile of optic neuritis: experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1991;109:1673-1678. Abstract
Ayberk G, Özveren MF, Yildirim T, et al. Review of a series with abducens nerve palsy. Turk Neurosurg. 2008;18:366-373.Full text Abstract
Jacobson DM, Trobe JD. The emerging role of magnetic resonance angiography in the management of patients with third cranial nerve palsy. Am J Ophthalmol. 1999;128:94-96. Abstract
Reference articles
1. Moran DT, Rowley JC 3rd, Jafek BW, et al. The fine structure of the olfactory mucosa in man. J Neurocytol. 1982;11:721-746. Abstract
2. Doty RL. The olfactory system and its disorders. Semin Neurol. 2009;29:74-81. Abstract
3. Gottfried JA, Deichmann R, Winston JS, et al. Functional heterogeneity in human olfactory cortex: an event-related functional magnetic resonance imaging study. J Neurosci. 2002;22:10819-10828.Full text Abstract
4. Damodaran O, Rizk E, Rodriguez J, et al. Cranial nerve assessment: a concise guide to clinical examination. Clin Anat. 2014 Jan;27(1):25-30.Full text Abstract
5. Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav. 1984;32:489-502. Abstract
6. Selhorst JB, Chen Y. The optic nerve. Semin Neurol. 2009;29:29-35. Abstract
7. Curcio CA, Allen KA. Topography of ganglion cells in human retina. J Comp Neurol. 1990;300:5-25. Abstract
8. Brazis PW. Isolated palsies of cranial nerves III, IV, and VI. Semin Neurol. 2009;29:14-28. Abstract
9. Holmes JM, Mutyala S, Maus TL, et al. Pediatric third, fourth, and sixth nerve palsies: a population-based study. Am J Ophthalmol. 1999;127:388-392. Abstract
10. Richards BW, Jones FR Jr, Younge BR. Causes and prognosis in 4,278 cases of paralysis of the oculomotor, trochlear, and abducens cranial nerves. Am J Ophthalmol. 1992;113:489-496. Abstract
11. Nemzek WR. The trigeminal nerve. Top Magn Reson Imaging. 1996;8:132-154. Abstract
12. Erman AB, Kejner AE, Hogikyan ND, et al. Disorders of cranial nerves IX and X. Semin Neurol. 2009;29:85-92. Abstract
13. Snell RS. Clinical neuroanatomy. Philadelphia, PA: Lippincott Williams & Wilkins; 2001.
14. Remley KB, Harnsberger HR, Smoker WR, et al. CT and MRI in the evaluation of glossopharyngeal, vagal, and spinal accessory neuropathy. Semin Ultrasound CT MR. 1987;8:284-300.
15. Afifi AK, Bergman RA. Functional neuroanatomy: text and atlas. 2nd ed. New York, NY: McGraw-Hill; 2005.
16. Castillo M, Mukherji SK. Magnetic resonance imaging of cranial nerves IX, X, XI, and XII. Top Magn Reson Imaging. 1996;8:180-186. Abstract
17. Parent A. Carpenter's human neuroanatomy. 9th ed. Baltimore, MD: Lippincott Williams & Wilkins; 1996.
18. Massey EW. Spinal accessory nerve lesions. Semin Neurol. 2009;29:82-84. Abstract
19. Warwick R, Williams PL. Gray's anatomy. 35th ed. Philadelphia, PA: WB Saunders; 1973.
20. Lalwani AK. Current diagnosis and treatment in otolaryngology: head and neck surgery. 2nd ed. New York, NY: McGraw-Hill; 2007.
21. Deutsch PG, Evans C, Wahid NW, et al. Anosmia: an evidence-based approach to diagnosis and management in primary care. Br J Gen Pract. 2021;71(704):135-138.Full text Abstract
22. Deems DA, Doty RL, Settle RG, et al. Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg. 1991;117:519-528. Abstract
23. Doty RL, Yousem DM, Pham LT, et al. Olfactory dysfunction in patients with head trauma. Arch Neurol. 1997 Sep;54(9):1131-40.Full text Abstract
24. Reden J, Mueller A, Mueller C, et al. Recovery of olfactory function following closed head injury or infections of the upper respiratory tract. Arch Otolaryngol Head Neck Surg. 2006 Mar;132(3):265-9.Full text Abstract
25. Marin C, Vilas D, Langdon C, et al. Olfactory Dysfunction in Neurodegenerative Diseases. Curr Allergy Asthma Rep. 2018 Jun 15;18(8):42.Full text Abstract
26. Zou YM, Lu D, Liu LP, et al. Olfactory dysfunction in Alzheimer's disease. Neuropsychiatr Dis Treat. 2016;12:869-75.Full text Abstract
27. Doty RL, Li C, Mannon LJ, et al. Olfactory dysfunction in multiple sclerosis. N Engl J Med. 1997;336:1918-1919. Abstract
28. Schwob JE, Szumowski KE, Leopold DA, et al. Histopathology of olfactory mucosa in Kallmann's syndrome. Ann Otol Rhinol Laryngol. 1993;102:117-122. Abstract
29. Lotfipour S, Chiles K, Kahn JA, et al. An unusual presentation of subfrontal meningioma: a case report and literature review for Foster Kennedy syndrome. Intern Emerg Med. 2011 Jun;6(3):267-9.Full text Abstract
30. Newman NJ, Dickersin K, Kaufman D, et al. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol. 1996;114:1366-1374. Abstract
31. Hayreh SS, Joos KM, Podhajsky PA, et al. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1994;118:766-780. Abstract
32. Stiebel-Kalish H, Hasanreisoglu M, Leibovici L. Aspirin following non-arteritic ischaemic optic neuropathy - a systematic review and meta-analysis. Neuro-Ophthalmol. 2010;34:14-19.
33. Repka MX, Savino PJ, Schatz NJ, et al. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol. 1983;96:478-483. Abstract
34. Nagel MA, Bennett JL, Khmeleva N, et al. Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis. Neurology. 2013;80:2017-2021.Full text Abstract
35. Optic Neuritis Study Group. Multiple sclerosis risk after optic neuritis: final Optic Neuritis Treatment Trial follow-up. Arch Neurol. 2008;65:727-732.Full text Abstract
36. Optic Neuritis Study Group. The clinical profile of optic neuritis: experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1991;109:1673-1678. Abstract
37. Beck RW, Gal RL, Bhatti MT, et al. Visual function more than 10 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. Am J Ophthalmol. 2004;137:77-83. Abstract
38. Phillips YL, Eggenberger ER. Neuro-ophthalmic sarcoidosis. Curr Opin Ophthalmol. 2010 Nov;21(6):423-9.Full text Abstract
39. Patterson SL, Goglin SE. Neuromyelitis Optica. Rheum Dis Clin North Am. 2017 Nov;43(4):579-591.Full text Abstract
40. Noble MJ, McFadzean R. Indirect injury to the optic nerves and optic chiasm. Neuroophthalmology. 1987;7:341-348.Full text
41. Borit A, Richardson EP Jr. The biological and clinical behaviour of pilocytic astrocytomas of the optic pathways. Brain. 1982;105:161-187. Abstract
42. Chun BY, Rizzo JF 3rd. Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches. Semin Pediatr Neurol. 2017 May;24(2):129-134.Full text Abstract
43. Newman NJ, Lott MT, Wallace DC. The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol. 1991;111:750-762. Abstract
44. Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease. BMJ. 2020 Jun 16;369:m1067.Full text Abstract
45. Marinelli JP, Marvisi C, Vaglio A, et al. Manifestations of Skull Base IgG4-Related Disease: A Multi-Institutional Study. Laryngoscope. 2020 Nov;130(11):2574-2580.Full text Abstract
46. Grzybowski A, Zülsdorff M, Wilhelm H, et al. Toxic optic neuropathies: an updated review. Acta Ophthalmol. 2015 Aug;93(5):402-10.Full text Abstract
47. Newman NJ. Optic neuropathy. Neurology. 1996;46:315-322. Abstract
48. Renowden SA, Harris KM, Hourihan MD. Isolated atraumatic third nerve palsy: clinical features and imaging techniques. Br J Radiol. 1993;66:1111-1117. Abstract
49. Lee AG, Onan HW, Brazis PW, et al. An imaging guide to the evaluation of third cranial nerve palsies. Strabismus. 1999;7:153-168. Abstract
50. Giraud P, Valade D, Lanteri-Minet M, et al. Is migraine with cranial nerve palsy an ophthalmoplegic migraine? J Headache Pain. 2007 Apr;8(2):119-22.Full text Abstract
51. Baker RS, Epstein AD. Ocular motor abnormalities from head trauma. Surv Ophthalmol. 1991;35:245-267. Abstract
52. Neetens A, Van Aerde F. Extra-ocular muscle palsy from minor head trauma: initial sign of intracranial tumour. Bull Soc Belge Ophtalmol. 1981;193:161-167. Abstract
53. Bijlsma MW, Brouwer MC, Kasanmoentalib ES, et al. Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study. Lancet Infect Dis. 2016;16:339-347. Abstract
54. Anwar S, Nalla S, Fernando DJ. Abducens nerve palsy as a complication of lumbar puncture. Eur J Intern Med. 2008;19:636-637. Abstract
55. Ayberk G, Özveren MF, Yildirim T, et al. Review of a series with abducens nerve palsy. Turk Neurosurg. 2008;18:366-373.Full text Abstract
56. Davies GE, Shakir RA. Giant cell arteritis presenting as oculomotor nerve palsy with pupillary dilatation. Postgrad Med J. 1994;70:298-299.Full text Abstract
57. Rush JA, Younge BR. Paralysis of cranial nerves III, IV, and VI: cause and prognosis in 1,000 cases. Arch Ophthalmol. 1981;99:76-79. Abstract
58. Galbraith RS. Incidence of neonatal sixth nerve palsy in relation to mode of delivery. Am J Obstet Gynecol. 1994;170:1158-1159. Abstract
59. Markey KA, Mollan SP, Jensen RH, et al. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol. 2016 Jan;15(1):78-91.Full text Abstract
60. Donahue SP, Taylor RJ. Pupil-sparing third nerve palsy associated with sildenafil citrate (Viagra). Am J Ophthalmol. 1998;126:476-477. Abstract
61. Migita DS, Devereaux MW, Tomsak RL. Cocaine and pupillary-sparing oculomotor nerve paresis. Neurology. 1997;49:1466-1467. Abstract
62. Cruccu G, Finnerup NB, Jensen TS, et al. Trigeminal neuralgia: New classification and diagnostic grading for practice and research. Neurology. 2016 Jul 12;87(2):220-8.Full text Abstract
63. Tanrikulu L, Hastreiter P, Bassemir T, et al. New Clinical and Morphologic Aspects in Trigeminal Neuralgia. World Neurosurg. 2016 Aug;92:189-196.Full text Abstract
64. Bennetto L, Patel NK, Fuller G. Trigeminal neuralgia and its management. BMJ. 2007;334:201-205. Abstract
66. Prasad S, Galetta SL. The trigeminal nerve. In: Goetz CG, ed. Textbook of clinical neurology. Philadelphia, PA: Saunders; 2007:165-184.
67. Siccoli MM, Bassetti CL, Sandor PS. Facial pain: clinical differential diagnosis. Lancet Neurol. 2006;5:257-267. Abstract
68. Feller L, Khammissa RAG, Fourie J, et al. Postherpetic Neuralgia and Trigeminal Neuralgia. Pain Res Treat. 2017;2017:1681765.Full text Abstract
69. Rosenbaum R. Neuromuscular complications of connective tissue diseases. Muscle Nerve. 2001;24:154-169. Abstract
70. Yuliati A, Rajamani K. Tolosa-Hunt Syndrome. Neurohospitalist. 2018 Apr;8(2):104-105.Full text Abstract
71. Gilchrist JM. Seventh cranial neuropathy. Semin Neurol. 2009;29:5-13. Abstract
72. Murakami S, Mizobuchi M, Nakashiro Y, et al. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med. 1996;12427-12430. Abstract
73. Eviston TJ, Croxson GR, Kennedy PG, et al. Bell's palsy: aetiology, clinical features and multidisciplinary care. J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1356-61.Full text Abstract
74. Gagyor I, Madhok VB, Daly F, et al. Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2019 Sep 5;9:CD001869.Full text Abstract
75. Sweeney CJ, Gilden DH. Ramsay Hunt syndrome. J Neurol Neurosurg Psychiatry. 2001;71:149-154.Full text Abstract
76. Kvestad E, Kvaerner KJ, Mair IW. Otologic facial palsy: etiology, onset, and symptom duration. Ann Otol Rhinol Laryngol. 2002;111:598-602. Abstract
77. Pachner AR, Steere AC. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology. 1985;35:47-53. Abstract
78. Pihlamaa T, Salmi T, Suominen S, et al. Progressive cranial nerve involvement and grading of facial paralysis in gelsolin amyloidosis. Muscle Nerve. 2016;53:762-769. Abstract
79. Shambaugh GE Jr, Clemis JD. Facial nerve paralysis. In: Paparella MM, Shumrick DA, eds. Otolaryngology, vol 2. Philadelphia, PA: Saunders; 1973:275.
80. Baloh RW. Clinical practice: vestibular neuritis. N Engl J Med. 2003;348:1027-1032. Abstract
81. Shirley SG, Folmer RL, McMenomey SO. Tinnitus and hyperacusis. In: Cummings CW, Flint PW, Harker LA, et al, eds. Cummings otolaryngology: head and neck surgery, vol 4. 4th ed. Philadelphia, PA: Elsevier Saunders; 2005:354-355, 2832-3243.
82. Lanvers-Kaminsky C, Zehnhoff-Dinnesen AA, Parfitt R, et al. Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies. Clin Pharmacol Ther. 2017 Apr;101(4):491-500.Full text Abstract
83. De Simone R, Ranieri A, Bilo L, et al. Cranial neuralgias: from physiopathology to pharmacological treatment. Neurol Sci. 2008;29(suppl 1):S69-S78. Abstract
84. Mulpuru SK, Vasavada BC, Punukollu GK, et al. Cardiovocal syndrome: a systematic review. Heart Lung Circ. 2008;17:1-4. Abstract
85. Massey EW, Heyman A, Utley C, et al. Cranial nerve paralysis following carotid endarterectomy. Stroke. 1984;15:157-159.Full text Abstract
86. de Beer F, Post B. Teaching neuroimages: Villaret syndrome. Neurology. 2010 Aug 31;75(9):e43.Full text Abstract
87. McGill F, Heyderman RS, Michael BD, et al. The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect. 2016 Apr;72(4):405-38.Full text Abstract
88. Mackie SL, Dejaco C, Appenzeller S, et al. British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis. Rheumatology (Oxford). 2020 Mar 1;59(3):e1-e23.Full text Abstract
89. Khaku A, Patel V, Zacharia T, et al. Guidelines for radiographic imaging of cranial neuropathies. Ear Nose Throat J. 2017 Oct-Nov;96(10-11):E23-E39.Full text Abstract
90. American College of Radiology. ACR appropriateness criteria: cranial neuropathy. 2022 [internet publication].Full text
91. Expert Panel on Neurologic Imaging: Kennedy TA, Corey AS, et al. ACR Appropriateness Criteria® Orbits Vision and Visual Loss. J Am Coll Radiol. 2018 May;15(5s):S116-S131.Full text Abstract
92. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6:805-815. Abstract
93. Frisen L, Royt WF, Tengroth BM. Optociliary veins, disc pallor and visual loss: a triad of signs indicating spheno-orbital meningioma. Acta Ophthalmol (Copenh). 1973;51:241-249. Abstract
94. Balcer LJ, Galetta SL, Bagley LJ, et al. Localization of traumatic oculomotor nerve palsy to the midbrain exit site by magnetic resonance imaging. Am J Ophthalmol. 1996;122:437-439. Abstract
95. Jacobson DM, Trobe JD. The emerging role of magnetic resonance angiography in the management of patients with third cranial nerve palsy. Am J Ophthalmol. 1999;128:94-96. Abstract
96. National Institute for Health and Care Excellence. Headaches in over 12s: diagnosis and management. Dec 2021 [internet publication].Full text
97. Miller NR. Unequal pupils can be seen in diabetic 3rd nerve palsy. Evid Based Eye Care. 1999;1:40-41.
98. Kim JH, Hwang JM, Hwang YS, et al. Childhood ocular myasthenia gravis. Ophthalmology. 2003;110:1458-1462. Abstract
99. Moster ML, Savino PJ, Sergott RC, et al. Isolated sixth-nerve palsies in younger adults. Arch Ophthalmol. 1984;102:1328-1330. Abstract
100. Schumacher-Feero LA, Yoo KW, Solari FM, et al. Third cranial nerve palsy in children. Am J Ophthalmol. 1999;128:216-221. Abstract
101. Green WR, Hackett ER, Schlezinger NS. Neuro-ophthalmologic evaluation of oculomotor nerve paralysis. Arch Ophthalmol. 1964;72:154-167. Abstract
102. Katusic S, Beard CM, Bergstralth E, et al. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol. 1990;27:89-95. Abstract
103. Olney RK. Neuropathies associated with connective tissue disease. Semin Neurol. 1998;18:63-72. Abstract
104. Expert Panel on Neurologic Imaging: Salmela MB, Mortazavi S, et al. ACR Appropriateness Criteria® Cerebrovascular Disease. J Am Coll Radiol. 2017 May;14(5s):S34-S61.Full text Abstract
105. Korzec K, Sobol SM, Kubal W, et al. Gadolinium-enhanced magnetic resonance imaging of the facial nerve in herpes zoster oticus and Bell's palsy: clinical implications. Am J Otol. 1991;12:163-168. Abstract
106. Gilliatt RW, Taylor JC. Electrical changes following section of the facial nerve. Proc R Soc Med. 1959;52:1080-1083.Full text Abstract
107. Goldbrunner R, Weller M, Regis J, et al. EANO guideline on the diagnosis and treatment of vestibular schwannoma. Neuro Oncol. 2020 Jan 11;22(1):31-45.Full text Abstract
108. Rapana A, Lamaida E, Bracale C, et al. Glossopharyngeal schwannoma, an uncommon posterior fossa tumor: diagnostical and therapeutical aspects: a case report. Clin Neurol Neurosurg. 1997;99:196-198. Abstract
109. Campbell WW. DeJong's the neurologic examination. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
110. McGinley MP, Goldschmidt CH, Rae-Grant AD. Diagnosis and Treatment of Multiple Sclerosis: A Review. JAMA. 2021 Feb 23;325(8):765-779.Full text Abstract
111. Aringer M, Brinks R, Dörner T, et al. European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. Ann Rheum Dis. 2021 Feb 10;:.Full text Abstract
112. Mead P, Petersen J, Hinckley A. Updated CDC Recommendation for Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):703.Full text Abstract
113. National Institute for Health and Care Excellence. Lyme disease. Oct 2018 [internet publication].Full text
Use of this content is subject to our disclaimer